FDA Launches Transparency Initiative to Increase Public Access to Compliance and Enforcement Data

Summary

The Food and Drug Administration (FDA) has made available a report detailing findings and recommendations from eight working groups aimed at enhancing transparency and public accessibility of the Agency's compliance and enforcement data.